Are you Dr. Gartner?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 41 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Karmanos Cancer Center
4100 John R Hwcrc 4th Fl
Detroit, MI 48201Phone+1 800-527-6266- Is this information wrong?
Summary
- Dr. Elaina Gartner, MD is an oncologist in Detroit, Michigan. She is currently licensed to practice medicine in Michigan. She is affiliated with DMC Harper University Hospital and DMC Detroit Receiving Hospital & University Health Center.
Education & Training
University of Michigan Health SystemFellowship, Hematology and Medical Oncology, 1999 - 2002
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1996 - 1999
Washington University in St. Louis School of MedicineClass of 1996
Certifications & Licensure
MI State Medical License 1999 - 2025
Clinical Trials
- Tanespimycin in Treating Women With Refractory Locally Advanced or Metastatic Breast Cancer Start of enrollment: 2005 Sep 01
- Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen Start of enrollment: 2005 May 01
- Safety Study of SGN-CD70A in Cancer Patients Start of enrollment: 2014 Aug 01
Publications & Presentations
PubMed
- 133 citationsEV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4-Positive Solid Tumors, Including Metastatic Urothelial Carcinoma.Jonathan E. Rosenberg, Srikala S. Sridhar, Jingsong Zhang, David Smith, D. Ruether, Thomas W. Flaig, Joaquina Baranda, Joshua M. Lang, Elizabeth R. Plimack, Randeep Sa...> ;Journal of Clinical Oncology. 2020 Feb 7
- 40 citationsA phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinomaShunji Takahashi, Motohide Uemura, Tomokazu Kimura, Yoshihide Kawasaki, Atsushi Takamoto, Akito Yamaguchi, Amal Melhem-Bertrandt, Elaina M. Gartner, Takashi Inoue, Rio...> ;Investigational New Drugs. 2020 Aug 1
- 331 citationsPivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy.Jonathan E. Rosenberg, Peter H. O'Donnell, Arjun Vasant Balar, Bradley Alexander McGregor, Elisabeth I. Heath, Evan Y. Yu, Matthew D. Galsky, Noah M. Hahn, Elaina M. G...> ;Journal of Clinical Oncology. 2019 Jul 29
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
DMC Detroit Receiving Hospital & University Health CenterDetroit, Michigan
DMC Harper University HospitalDetroit, Michigan
